SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086168
Filing Date
2023-11-13
Accepted
2023-11-13 16:30:25
Documents
58
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_lucyscientific.htm   iXBRL 10-Q 502935
2 CERTIFICATION f10q0923ex31-1_lucy.htm EX-31.1 9156
3 CERTIFICATION f10q0923ex31-2_lucy.htm EX-31.2 9302
4 CERTIFICATION f10q0923ex32-1_lucy.htm EX-32.1 3769
5 CERTIFICATION f10q0923ex32-2_lucy.htm EX-32.2 3684
  Complete submission text file 0001213900-23-086168.txt   3268847

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE lsdi-20230930.xsd EX-101.SCH 34114
7 XBRL CALCULATION FILE lsdi-20230930_cal.xml EX-101.CAL 36642
8 XBRL DEFINITION FILE lsdi-20230930_def.xml EX-101.DEF 172065
9 XBRL LABEL FILE lsdi-20230930_lab.xml EX-101.LAB 356521
10 XBRL PRESENTATION FILE lsdi-20230930_pre.xml EX-101.PRE 184825
52 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_lucyscientific_htm.xml XML 254255
Mailing Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6
Business Address 301-1321 BLANSHARD STREET VICTORIA A1 V8W 0B6 778-410-5195
Lucy Scientific Discovery, Inc. (Filer) CIK: 0001865127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41616 | Film No.: 231399305
SIC: 2834 Pharmaceutical Preparations